(Q36796711)

16 August 2017

title

Isolated limb perfusion with TNF alpha and melphalan in a rat osteosarcoma model: a new anti-tumour approach (English)

1 reference

16 August 2017

0 references

Manusama ER

1

1 reference

16 August 2017

Stavast J

2

1 reference

16 August 2017

Durante NM

3

1 reference

16 August 2017

Marquet RL

4

1 reference

16 August 2017

Eggermont AM

5

1 reference

16 August 2017

publication date

1 April 1996

1 reference

European Journal of Surgical Oncology

16 August 2017

published in

1 reference

16 August 2017

volume

22

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

152-157

1 reference

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

Synergistic antitumour effect of recombinant human tumour necrosis factor alpha with melphalan in isolated limb perfusion in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

Differences in effectiveness of combined treatments with ionizing radiation and vinblastine, evaluated for experfaental sarcomas and squamous cell carcinomas in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

Serum-free in vitro bioassay for the detection of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

High-flow isolation perfusion of the rat hind limb in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

Effect of tumour necrosis factor and lipid A on functional and structural vascular volume in solid murine tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

Multiple facets of induction of tumour necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

VWF release and platelet aggregation in human melanoma after perfusion with TNF alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNF alpha)

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

A model for the investigation of factors influencing haemorrhagic necrosis mediated by tumour necrosis factor in tissue sites primed with mycobacterial antigen preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

Recombinant human tumor necrosis factor mediates regression of a murine sarcoma in vivo via Lyt-2+ cells

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2896%2990671-X

7 January 2021

10.1016/S0748-7983(96)90671-X

Identifiers

DOI

1 reference

16 August 2017

1 reference